Abstract Paroxysmal kinesigenic choreoathetosis (PKC) is a paroxysmal movement disorder of unknown cause. Although the PKC-critical region (PKCCR) has been assigned to the pericentromeric region of chromosome 16 by several studies of families from various ethnic backgrounds, the causative gene has not yet been identified. In the present study, we performed linkage and haplotype analysis in four new families with PKC, as well as an intensive polymerase chain reaction (PCR) based mutation analysis in seven families for a total of 1,563 exons from 157 genes mapped around the PKCCR. Consequently, the linkage/haplotype analysis revealed that PKC was assigned to a 24-cM segment between D16S3131 and D16S408, the result confirming the previously defined PKCCR, but being unable to narrow it down. Although the mutation analysis of the 157 genes was unsuccessful at identifying any mutations that were shared by patients from the seven families, two nonsynonymous substitutions, i.e., 6186C>A in exon 3 of SCNN1G and 45842A>G in exon 29 of ITGAL, which were segregated with the disease in Families C and F, respectively, were not observed in more than 400 normal controls. Thus, one of the two genes, SCNN1G and ITGAL, could be causative for PKC, but we were not able to find any other mutations that explain the PKC phenotype.
Introduction
Paroxysmal kinesigenic choreoathetosis (PKC; MIM 128200) is a paroxysmal movement disorder characterized by recurrent and brief attacks of unilateral or bilateral involuntary movements, including dystonic posturing, chorea, athetosis, and ballism, which are precipitated by the sudden onset of movements (Kato et al. 2006) . The attacks can last as long as a few seconds to a few minutes, occur up to 100 times daily, but usually manifest in childhood or early adolescents, and commonly decrease with age. There is no loss of consciousness during these attacks. The attacks are responsive to anticonvulsants such as carbamazepine or phenytoin. Electroencephalogram (EEG) analysis demonstrates normal or nonspecific abnormalities. Neuroimaging and neuropathological studies resulted in unremarkable findings (Sadamatsu et al. 1999; Nagamitsu et al. 1999) . The etiology and pathophysiology of PKC still remain unclear. Some neurologists consider PKC as a form of reflex epilepsy, whereas others believe that basal ganglia dysfunction may play a role in its cause (Kato et al. 2006) . Most (40-70%) were familial cases in which PKC was transmitted in an autosomal dominant mode of inheritance with incomplete penetrance (Tomita et al. 1999; Valente et al. 2000) . Males are affected more often than females, with an estimated ratio of 3-4:1 (Bhatia 1999) .
We previously performed a genome-wide linkage and haplotype analysis in eight Japanese families with PKC and defined the disease locus within a 12.4-cM region between D16S3093 and D16S416 at 16p11.2-q12.1 (Tomita et al. 1999 ). This PKC-critical region (PKCCR) was confirmed by others (Bennett et al. 2000; Swoboda et al. 2000; Valente et al. 2000; CuencaLeon et al. 2002) . In addition, mapped regions for other conditions probably allelic to PKC, such as infantile convulsions and paroxysmal choreoathetosis (ICCA; MIM 602066) and benign familial infantile convulsions (BFIC2; MIM 605751), shared with that for PKC (Lee et al. 1998; Hattori et al. 2000; Swoboda et al. 2000; Caraballo et al. 2001; Weber et al. 2004 ). Nevertheless, mutations in any genes within the PKCCR have remained uncovered.
Here, we describe the results of the mutation analyses of seven PKC families for a total of 157 genes located at or around the PKCCR, together with linkage/haplotype analysis of four newly identified families.
Materials and methods

Subjects
The subjects studied included seven families (Families A-G) with PKC. Two of them (Families F and G) corresponded respectively to Families 1 and 3 in our previous report (Tomita et al. 1999) , and five other families (Families A-E, Fig. 1 ) were those which were newly collected. A total of 21 members, including 16 PKC patients from four of the five families (Families A-D), underwent a linkage and haplotype analysis. In addition, one of each affected individual (we further call them representative patients) chosen from all seven families was subjected to mutation analysis. Blood samples were collected from all participants after obtaining written informed consent, and the study protocol was approved by the Committee for Ethical Issues on Human Genome and Gene Analysis at Nagasaki University.
Genotyping and linkage analysis
Genomic DNA was isolated from the blood lysate of the 21 participants by phenol-chloroform extraction, followed by ethanol precipitation. To try to narrow down the PKCCR, we performed genotyping and haplotype analysis in the four newly collected PKC families, using 13 microsatellite markers (Table 1) located to a 36-cM region at 16p12-q21 to which PKC has been shown to be linked, as well as using three 
Mutation analysis
We performed PCR-based mutation analysis of the seven representative patients with typical features of PKC. Sequences examined for mutations among the seven patients included those of 1,371 coding exons, excluding the 3¢-UTR and 5¢-UTR in 117 genes, located at the PKCCR between D16S3093 and D16S416 ( Table 1 ). The analysis in five families (Families A and C-F) was expanded to an additional 192 exons of 40 other genes, whereas because of depletion of genomic DNA, an expanded analysis was not done in the remaining two families. Thus, a total of 1,563 exons in 157 genes were analyzed for mutation (primer sequences are available on request).
Real-time quantitative PCR
We performed real-time quantitative PCR in six representative patients from Families A and C-G. Six pairs of primers and TaqMan probes were designed for exons 1, 6, and 13 of SCNN1G, and for exons 1, 16, and 30 of ITGAL. PCR was carried out in a 10-ll reaction mixture containing 5 ll of 2·TaqMan Universal PCR Master mix (Applied Biosystems, Foster City, CA), 0.4 lM each of primer, a 0.2-lM probe, and 10 ng DNA under the conditions of 2 min at 50°C, 10 min at 95°C, 40 cycles of 15 s at 95°C, and 1 min at 60°C, with a 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA).
Results
The haplotype analysis showed that all affected individuals in the four new families share an allele at each locus examined between D16S3131 and D16S408 (Fig. 2) . One end of the shared region was defined by a recombination between D16S3131 and D16S3093 in individual III-3 in Family A, and the other end by a recombination between D16S514 and D16S408 in individual III-1 in the same family. These results defined a minimum PKCCR in the four new families within an approximately 24-cM segment between D16S3131 and D16S408. Therefore, the present linkage/haplotype analysis did not contribute to narrow down the previously defined PKCCR. Among a total of 1,563 exons of 157 genes analyzed, we detected 243 base alterations in the seven representative patients (Fig. 3) , 36 of which were base substitutions in coding regions and have not been reported in the dbSNP database (http://www.ncbi.nlm.- CAAGACTAACGCTGATGGCT  GACAGTGAGGTGGGAATCAAA  D16S417  CTGTCCAACATGCAGCC  TGAAGTCAATCCCACTTGAA  D16S3131  CTGCTTCCATCTTGCC  CTAGCCCCCAAATGTG  D16S3093  CAAGGGCAAAACTCCAT  CCAAAAGGTTGATTCTCTG  AC007353-M1  GCTTAACTACATTTTATTCAAGGTTG  TCTGTGGTAGAGAGGCAAAGA  AC092368-M1  GTTTACCAGCCATTTTTAATCAACA  TGAATAAGTGTGTCTTTCAACAAAATT  AC092721-M3  GCCCTGTAATATAATTTGAAGTTG  GGGTTCAAGTGATTCTCCTG  D16S3136  CTCACCTATTGCCCTCAAGAA  CAGAATCTTATGCCATTATT  D16S416  CATAGGACCCTCAGATGTATA  CTGCCTATGGCTAAGAGGACA  D16S408  TGTAACCTTGTGTGCATCCT  CACTCTTATCCCAGGAACCC  D16S514  CAATTCCTTGATGCTACCAT  CTTGTCTAGTGGCTGGAATA  D16S3143 GCTACTGAGGAAACCTTATCC GGCCATTACAGGAAGTGC Primers of D16S3068 were purchased from the ABI PRISM Linkage Mapping Sets LMS (Applied Biosystems, Foster City, CA)
nih.gov/SNP/). Seven of the alterations in six genes were nonsynonymous substitutions resulting in amino-acid substitutions ( Table 2) . Five of such nonsynonymous substitutions in four genes were observed both in some patients and among 100 normal control individuals. The remaining two, i.e., 6186C>A in exon 3 of SCNN1G (the gene for sodium channel, nonvoltage-gated 1, gamma) and 45842A>G in exon 29 of ITGAL (the integrin alpha L precursor gene), observed in Families C and F, respectively, were not observed among more than 400 normal controls. The real-time quantitative PCR analysis did not detect a duplication or a deletion within the two genes. Of the 35 intronic base changes we identified in the seven patients, none were located at the acceptor or donor splice sites (Fig. 3) . G-banding chromosome analysis at the 400-band level and C-banding analysis revealed that all five patients from Families B-D, F, and G had a normalsized heterochromatin block on chromosome 16 without an inversion (data not shown). Table 2 . None of the novel intronic SNPs are located at any of the acceptor or donor splice sites A total of 75 SNPs not reported in the dbSNP database were found in this study Four SNPs found in 5¢-UTR or 3¢-UTR happened to be included in the sequenced regions *Analyzed in seven representative patients: E/I=exon or intron; AA=inferred amino acid change from nonsynonymous SNP; U=UTR
Discussion
The PKCCR was assigned to a segment between D16S3093 and D16S416 in eight Japanese families (Tomita et al. 1999) . It was also mapped between D16S3100 and D16S771 in an Afro-Caribbean family (Bennett et al. 2000) , between D16S3131 and D16S3396 in 11 families of diverse ethnicity (Swoboda et al. 2000) , between D16S3145 and GATA140E03 in a Spanish family (Cuenca-Leon et al. 2002) , and a 24-cM segment between D16S3131 and D16S408 in the present study (Fig. 4) . Thus, the shortest region of overlap (SRO) did not become narrower than a 12.4-cM segment detected by Tomita et al. (1999) . Valente et al. (2000) assigned a form of PKC (a second PKC locus, EKD2), in an Indian family, to a segment between D16S416 and D16S503, the region distinct from those mapped by Tomita et al. (1999) and by Swoboda et al. (2000) . Furthermore, two other clinical entities, ICCA and BFIC2, were assigned to a region encompassing the centromere of chromosome 16 (Lee et al. 1998; Hattori et al. 2000; Swoboda et al. 2000; Caraballo et al. 2001; Weber et al. 2004) . Since all of these loci were confined to a relatively small region, it is likely that all of these paroxysmal movement dis- Fig. 4 The PKC-critical region (PKCCR) summarized by five mapping studies (Tomita et al. 1999; Bennett et al. 2000; Swoboda et al. 2000; Cuenca-Leon et al. 2002, present study) , as well as a seemingly second PKC locus (EKD2) by Valente et al. (2000) . The location of markers and intermarker distances are from the Gé né thon map (Dib et al. 1996) orders actually belong to one disorder and are allelic, as suggested previously (Tomita et al. 1999) . We searched for mutations in almost all proteincoding genes mapped at the PKCCR. In addition, we also analyzed four ion-channel-related genes (CACNG3, SCNN1B, SCNN1G, and CNGB1), albeit located outside the PKCCR, since many episodic neurologic disorders, such as muscle diseases, epilepsy, and movement disorders, are known as ion-channel abnormalities . However, 14 coding exons in seven genes (Table 3) were not analyzed because of difficulties in PCR-amplification.
In the present study on a total of 157 genes, we failed to identify any causative mutations that can explain PKC in all of the seven families examined. However, two nonsynonymous substitutions, 6186C>A in exon 3 of SCNN1G and 45842A>G in exon 29 of ITGAL, which were co-segregated with PKC in Families C and F, respectively, which were not found in normal control individuals, might be implicated in PKC. In other words, they were not able to be totally ruled out from the candidacy for PKC. It thus remains to be investigated whether another mutation in either gene is found in other PKC families.
Although the mapping of PKC was successful in at least nine studies, causative mutations have been uncovered. This may imply that PKC is caused by aberrations other than exonic mutations, such as a deletion or insertion, in the promoter regions, including the 5¢-UTR or 3¢-UTR. However, there is still a possibility for usual exonic mutations in a novel gene not annotated in public databases. As PKC itself is, generally, a viable disorder with which patients may show high reproductive fitness, such a mutated allele may be transmitted through many generations. A chromosomal rearrangement is another possibility. The pericentromeric region of chromosome 16 has a large heterochromatin (C-band) block that contains several duplicated regions, through which, frequent chromosomal rearrangements occur (Loftus et al. 1999) . It remains also to be seen whether PKC patients within a family share such a variant.
